A microcarrier-based bioreactor offers many advantages in growing human mesenchymal stem cells. For example, hMSCs secrete high amounts of extracellular matrix, which enhances their adhesion on ...

A single-use, stirred tank bioreactor process from MilliporeSigma allows for scalable, cell-based production of viral vaccines, and avoids the drawbacks of egg-based production.

Researchers developed a novel microcarrier for large-scale cell production and expansion that offers higher yield and cost-effectiveness compared to traditional methods, and reduces steps required ...

Jeroen Verheyen, Co-Founder & CEO, Semarion, said: “We are delighted to open the Early Adopter Programme for our SemaCyte Microcarrier Platform to researchers working in drug discovery.

The partnership will integrate SPT Labtech’s firefly ® liquid handling platform with Semarion’s SemaCyte ® microcarrier technology to develop a flexible, scalable, and automated workflow ...

Researchers from Singapore-MIT Alliance for Research and Technology, MIT's research enterprise in Singapore, have developed a novel microcarrier for large-scale cell production and expansion that ...

Microcarrier Market Poised to Reach US$ 4.07 Billion by 2032 with Robust CAGR of 8.87% - Vaccine Manufacturing and Therapeutics, Investments in Biopharmaceutical R&D - ResearchAndMarkets.com.

The partnership will integrate SPT Labtech’s firefly ® liquid handling platform with Semarion’s SemaCyte ® microcarrier technology to develop a flexible, scalable, and automated workflow ...